Investorideas.com - Cannabis Stock News: Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) Secures Supply Agreement with British Columbia Liquor Distribution Branch (BCLDB)
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Thursday, September 24, 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 472 (NASDAQ: $NEPT) (TSXV: $NUMI.V) (CSE: $BAMM.C) (CSE: $CURA.C) (TSX: $IN.TO)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 472 (NASDAQ: $NEPT) (TSXV: $NUMI.V) (CSE: $BAMM.C) (CSE: $CURA.C) (TSX: $IN.TO)
Today's podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC, September 24, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/092420-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/09241NEPT-NUMI-BAMM-CURA-IN.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
In today’s podcast we look at a few public announcements.
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) announced entering into an agreement with the British Columbia Liquor Distribution Branch (BCLDB), the wholesaler and public retailer of non-medical cannabis throughout the province, for the sale and distribution of Neptune's new proprietary Mood Ring product line.
"We are pleased to be partnering with BCLDB to bring Mood Ring to the province of British Columbia. This will allow Neptune to bring the benefits of legal cannabis to a larger group of people," said Michael Cammarata, Chief Executive Officer and President of Neptune.
The agreement marks the launch of Neptune's Mood Ring product line for sale into the Canadian non-medical cannabis market. Products are expected to be available for purchase this fall through the BC Cannabis Store online, in addition to its 20 government-run retail locations across British Columbia. Additionally, the Mood Ring product line will be available to the 271 private licensed retailers in British Columbia.
The initial product rollout will include Mood Ring's High CBD products and Mood Ring's Classic Hashish and Legacy Hashish. Mood Ring will deliver sustainable and premium CBD and THC products to the non-medical cannabis market.
Mood Ring will use Neptune's proprietary cold ethanol extraction process technology to create full spectrum extracts for the Company's CBD products and newly implemented solventless extraction for THC concentrates.
Numinus Wellness Inc. (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, announced that it has begun cultivating Psilocybe mushrooms, for the purpose of psilocybin production, at its 7000 square-foot Health Canada licensed facility. Psilocybin-assisted psychotherapy is currently being studied as a treatment for a range of mental health conditions including depression, anxiety, and substance use disorders.
Under its Health Canada licence for the production and extraction of psilocybin from mushrooms, Numinus intends to cultivate and harvest the mushrooms for a variety of purposes including:
● development of standardized extraction methods
● exploration of product formulations of naturally occurring psilocybin
● development and evaluation of qualitative and quantitative mycochemicals standardized test methodologies
● exploration of the ability to investigate naturally occurring psilocybin's efficacy as an alternative supply to synthetic psilocybin currently used in research
● ultimately, the delivery of safe, evidence-based psilocybin-assisted psychotherapy at clinics including its own
"We are thrilled to start growing mushrooms at our laboratory under our Health Canada licence," says Michael Tan, Chief Operating Officer. "We envision a day when the option of natural, plant-based psilocybin is available for use in therapies at Numinus Clinics and by others, and this is a tangible step towards that goal."
Numinus' vertically integrated ecosystem positions the Company to be a first-in-market, trusted leader in the delivery of psychedelic-assisted psychotherapies when regulated. From product development and supply, to analytics and testing, to clinical protocol development and implementation science in partnership with leading research organizations, the ecosystem approach allows Numinus to ensure quality control and best-in-class delivery with steady revenue streams to support its developments.
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ), a debt free multi-state operator focused on limited license markets, announced the launch of Pretzel Bites into the California market and engagement of Harbor Access LLC for investor relations services.
"We are excited to expand our California branded product portfolio with the addition of our popular Pretzel Bites edibles," stated Michael Mills, CEO of Body and Mind. "We have been selling Pretzel Bites in the Nevada market with strong customer feedback and special releases including Fourth of July and Electric Circus drops. We feel Pretzel Bites are a timely addition to the expanding California market of new and cannacurious consumers who are seeking tested, tasty alternatives to inhaled consumption. Our pretzel bites each contain 10mg of THC distillate in butter caramel squeezed between salted pretzels and dipped in milk chocolate. Pretzel bites add to our expanding California branded product portfolio, which includes BaM Stix prerolls, Body and Mind preroll packs, distillate and live-resin cartridges, G-Pen cartridges and concentrates including live resin, shatter and wax."
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced that its Select brand is launching a vape pen in collaboration with Belushi's Farm, available exclusively in Oregon. Select, America's #1 Cannabis Oil Brand, will release the limited-edition product with the famous Captain Jack's strain, grown exclusively on Belushi's Farm and featured in the new reality series GROWING BELUSHI on The Discovery Channel. The Captain Jack's x Select strain will premiere at Curaleaf's Portland dispensary and will also be available at selected dispensaries throughout Oregon.
Jack Murtha, known as "Captain Jack," is a pioneer of cannabis cultivation who spent more than 40 years perfecting his namesake strain, based on Gulzar Afghanica, which he first encountered in 1971 during a hot summer in the valley of the Kush Mountains in Afghanistan. Learning the Afghani process for cultivating the plant, Captain Jack was gifted seeds by the village elders and he's been growing the pure landrace strain from seed to flower ever since.
"After working to perfect his strain, which has roots in Afghanistan's 4,000-year-old traditions, Captain Jack is working with Belushi's Farm and Select to turn this legendary strain into oil," said Jim Belushi. "This strain has never been tweaked in a laboratory or compromised, making it a perfect match for Select's unparalleled quality. And, I can say it's likely it has inspired many historic comedy sketches throughout the mid to late '70s. Thanks to its long and storied history in the halls and offices of 30 Rock, we call Captain Jack's strain 'the Smell of SNL.'"
The Captain Jack's x Select vape pen will be available in limited quantities now available at Curaleaf's Portland dispensary. As the only Captain Jack product on the market, this partnership is the only way consumers can currently experience the high-quality oil they expect from Select with the creative power of the Captain Jack's strain.
"Our goal with Select is to put the consumer first and deliver the best possible experience with full flavor and a smooth feel – without sacrificing on high quality control standards and superior testing standards," said Joe Bayern, President at Curaleaf. "Jim holds the same high-quality approach at his farm, making this partnership a perfect pairing, and with the creativity and legacy behind the Captain Jack's strain, we're able to provide a product we know Oregonians will love."
The launch of the Captain Jack's x Select vape pen comes on the heels of Belushi's new Discovery Channel television show, GROWING BELUSHI, which gives viewers a peek behind the curtain of the Belushi's Farm operations in Oregon. This month, Belushi launched a limited-edition Blues Brothers x Grassroots flower in the Bubba Diagonal strain, available exclusively in Chicago. In July 2020, Curaleaf closed on its acquisition of Grassroots, giving the company the opportunity to continue developing innovative products and serving communities across the United States.
In response to the ongoing wildfires that have devastated Southern Oregon and displaced more than 42,000 residents, Curaleaf Oregon, Select, Jim Belushi and Belushi's Farm have joined forces with a coalition of local cannabis companies to create the Jackson County Fire Relief Fund. Together, the coalition has pledged to raise $420,000 for the United Way of Jackson County, where funds will support the recovery of those affected in Jackson County, home to many of Oregon's premier cannabis and hemp companies.
The Select brand was founded in Portland, Oregon and in February 2020 the brand was acquired by leading multi-state-operator Curaleaf. The company continues to roll out new products to serve the Oregon community, most recently with the launch of Select Elite Live, a high quality, high potency oil that offers a wide variety of strain-specific flavor and effects. Select products are available at Curaleaf Portland and in dispensaries state-wide. To find a dispensary near you that carries Select products, go to www.selectbetter.com and click "Find Us" for an interactive map of locations.
InMed Pharmaceuticals Inc. (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol ("CBN"), today announced that all subjects participating in its second Phase 1 clinical trial with INM-755 have completed treatment. INM-755 is being developed as a topical CBN-based cream to potentially treat Epidermolysis Bullosa ("EB") as well as potentially other dermatological diseases.
The 755-102-HV clinical trial is a randomized, double-blind, vehicle-controlled, Phase 1 study designed to evaluate the safety and tolerability of INM-755 cream applied daily on epidermal wounds in healthy volunteers. Eight adult subjects were treated with two strengths of INM-755 cream over a 14-day treatment period. As with InMed's first Phase 1 clinical trial with INM-755, the 755-102-HV trial is being conducted at the Centre for Human Drug Research in Leiden, the Netherlands.
Despite the COVID-19 pandemic and the resulting restrictions that have affected clinical development programs worldwide, the full treatment phase of this second Phase 1 trial was achieved with only a modest delay to the original timeline. With completion of both the 755-101-HV and the 755-102-HV treatment phases, and assuming positive safety and tolerability data of INM-755 on both intact skin and epidermal wounds, the Company will be better positioned to advance detailed planning for the first efficacy trial in EB patients.
InMed anticipates reporting results from both Phase 1 trials in the second half of calendar 2020 and, assuming a positive safety profile for INM-755, submitting regulatory filings for the first efficacy trial in EB patients in early 2021.
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:https://www.investorideas.com/About/Private_Policy.asp Disclosure: Cannabis Suisse Corp. (OTC: CSUI), is a paid featured company on Investorideas.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Wednesday, September 23, 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 471 - Interview with Tim Moore and Susan Chappelle, Co-CEO’s of Havn Life Sciences (CSE: $HAVN.C)
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 471 - Interview with Tim Moore and Susan Chappelle, Co-CEO’s of Havn Life Sciences (CSE: $HAVN.C)
Today’s podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC, September 23, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/092320-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/09231Interview-HAVN.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
In today’s podcast Investorideas interview Tim Moore and Susan Chappelle, the Co-CEO’s of Havn Life Sciences Inc. (CSE : HAVN), a biotechnology company focused on unlocking human potential using evidence-informed research, and developing standardized psychoactive compounds derived from plants and fungi. We discuss the company’s most recent announcement that, on August 31, 2020, its wholly-owned subsidiary, HAVN Research Inc., was granted a Section 56 exemption by Health Canada, pursuant to which it now has the ability to possess certain amounts of pure psilocybin for scientific purposes, specifically for the research and development of quality control methods.
Havn Life intends to immediately begin work on experiments with the objective of developing a set of methods for the safe, standardized, quality-controlled production of medical compounds extracted from the Psilocybe spp. mushroom.
"We are thrilled to be among the first to receive permission from the Canadian government to begin work with psilocybin", stated Tim Moore, Co-CEO of Havn Life. "This important milestone will enable Havn to begin working toward creating method-validation and analytical chemistry to standardize methods for quality control and testing of these substances."
"Having access to compounds is essential in order to further research in the medical field. This is the start of our journey into developing standardized protocols to ensure that as this industry grows, we understand efficient new methodology", stated Susan Chapelle, Havn Life Co-CEO, noting the advent of new technology and variables in extraction have changed significantly in the last decade.
Moore and Chappelle went on to discuss the company’s two pronged approach to the psychedelic market as well as what separates them from other competitors entering this new landscape.
“Haven Life is an exciting opportunity in that we are focusing on the supply chain. Basically there have been very few companies focusing on supply chain. Most of the research going on right now is with synthetics, but the people using these compounds use them in their natural forms. Creating a natural compound library so researchers can extract the compounds they need to make sure that the human performance and outcomes are stable and repeatable is such an important space to be in. Our team also has strong retail, scientific and policy experience makes us well attuned to the regulatory space as well. We’ve placed ourselves in the supply chain as opposed to the end user clinic space because we think this a much better opportunity to ensure safe, standardized and effective compounds,” commented Susan Chappelle.
Chappelle also went on to discuss how this industry aims to deal with the very unique and subjective effects and experience of psilocybin saying, “If you’re picking a mushroom from the woods, you have no idea how much psilocybin is in that mushrooms. Having the researchers have safe standardized compounds and dosing of the effective ingredients and then be in a clinic, a safe environment, I think the landscape over the next few years is going to rapidly change.”
Tim and Susan went on to discuss in more detail the importance of creating a standardized supply chain, the importance of working with natural whole plant compounds versus synthetic compounds as well as the future of psilocybin research.
To find out more about Havn Life Sciences visit their website here.
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: Cannabis Suisse Corp. (OTC: CSUI ),is a paid featured company on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
#CBD and #Hemp #stocks to watch (OTC: $CSUI) (OTC: $MJNA) (CSE: $TGIF.C) (OTCQX: $TGIFF), (TSXV: $KHRN.V) (OTCQX: $KHRNF) as Distribution Platforms Grow Market
#CBD and #Hemp #stocks to watch (OTC: $CSUI) (OTC: $MJNA) (CSE: $TGIF.C) (OTCQX: $TGIFF), (TSXV: $KHRN.V) (OTCQX: $KHRNF) as Distribution Platforms Grow Market
Point Roberts WA, Delta, BC –September 23, 2020 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a special report on the continued growth of the global CBD/hemp industry as additional international markets come into play and how smart companies hedging for the future are putting their focus into globalized distribution systems.
Read this article, featuring CSUI in full at https://www.investorideas.com/news/2020/cannabis/09231CBD-HEMP-Distribution-Platforms.asp
As we see more global acceptance of the hemp/CBD industry, whether in the form of new import/export regulations coming into play in South America, potential markets opening up South East Asia, Japan and South Korea or larger companies like Amazon being more acceptant of hemp/CBD products, the CBD industry is going global faster than many anticipated, especially in the midst of a global pandemic. That being said, one of the most significant drivers of this industry today is the renewed focus on health and wellness and immune boosting products that we’ve seen ramp up due to the COVID-19 pandemic.
One company based out of Switzerland, Cannabis Suisse Corp. (OTC: CSUI), a fully-licensed Swiss cannabis cultivation and distribution company for recreational tobacco products and medical CBD oils, recently announced its own online expansion plans including the upcoming launch of a new brand on Amazon.
Сannabis Suisse Corp. is developing its own line of products including hemp oil, hemp protein, hemp gummies and hemp hearts with all the appropriate certificates and licenses, for sale on Amazon.
This news follows a recent announcement for online distribution of its cannabis and CBD products with uWeed from their retail outlets and online store (www.uweed.ch).
The expansion into online sales of hemp gives the company, which is headquartered in Switzerland, wider access and inroads into US markets as the legal environment for CBD products evolves.
Mr. Alain Parrik, COO & Director said, “Amazon is an important distribution outlet for us as we ramp up for expansion across multiple online retail platforms. Introducing a new line of hemp products paves the wave for additional products in the future.”
Cannabis Suisse Corp. will be in compliance with Amazon rules and respects their position that CBD is currently banned on Amazon but hemp products are not.
The Company, as a registered manufacturer of both products will continue to use flowers with the highest concentration of CBD. For the new Amazon product line, oil will be squeezed from the seeds allowing Cannabis Suisse to use the whole plant in its production and benefit from it.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
Source: Brightfield Group Quarterly CBD Consumer Survey, Q2, 2020, Sample size = 5,000
Looking more to domestic markets, 1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), a vertically-integrated cannabis consumer packaged goods company with a diverse portfolio of consumer-driven brands, recently announced that it has set up distribution of its Canna Hemp™ line of wellness products in conjunction with CBD Plus, the largest and most trusted supplier of CBD products across the United States.
The Company reports that its wholly-owned subsidiary, Infused MFG, signed a Master Services and Supply Agreement with MCV Enterprises LLC, an Oklahoma company doing business as CBD Plus and CBD Plus USA, for the marketing and sale of Canna Hemp™ products in CBD Plus corporate-owned and franchisee brick and mortar retail stores. The one-year Agreement includes a 45-day trial period, effective immediately.
CBD Plus is focused in the Midwest and Southern US, with over 120 locations and growing - in Texas, Oklahoma, Kansas, Arkansas, Tennessee, Georgia, Florida, North Carolina, and Maryland. The partnership with CBD Plus is another important step for the Company as it builds the Canna Hemp™ line as a leading brand in the US CBD market. According to the latest outlook by the Brightfield Group, hemp-based CBD US sales will reach $12.4 billion by 2023 and $16.8 billion by 2025.
Mr. Eugene Ruiz, President of 1933 Industries said, "CBD Plus is a well-respected source of safe, legal and affordable CBD products that meet the highest standards in the industry. We are pleased that our Canna Hemp™ line meets and exceeds those high standards. We look forward to collaborating with CBD Plus to increase awareness and education regarding the benefits and value of CBD in our everyday lives."
"CBD Plus and its family of franchisees is proud to announce its relationship with 1933 industries", said Mr. Charles V. Reynolds III, CEO of CBD Plus. "We look forward to introducing Canna Hemp™ products to our entire customer base nationwide. Quality Assurance and Cannabis Education have always been cornerstones of the CBD Plus USA mission, and we are excited to partner with a brand such as Canna Hemp™ that shares those values. We remain committed to helping educate the public on all of the benefits and uses of quality CBD, and we believe this relationship aligns with our goals."
CBD Plus has been committed to improving the lives of communities since 2017, and has now grown into a trusted source of CBD products in the US. Founded on the cornerstone of empowering customers to live their best lives, CBD Plus has become an authoritative advocate for CBD, and a dedicated educator of the benefits of CBD oil. CBD Plus offers a variety of self-care and lifestyle products with CBD that exceeds the industry standard of quality, producing carefully extracted, pesticide-free, and non-GMO products.
Looking back to the international market, Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, recently announced that its subsidiary HempMeds® Brasil had its best revenue month ever in Company history in August 2020.
“Since 2015, HempMeds® Brasil has sold more than 80,000 units of cannabidiol (CBD) to Brazilian citizens,” said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. “We are proud to be the recipients of the first permits to import CBD into Brazil and we have been able to become industry leaders there.”
“Our Company was formed and is led by Brazilians – we care immensely about providing people here with affordable, high-quality CBD products that are legal and scientifically-proven,” said HempMeds® Co-CEO, Caroline Heinz. “We have showcased to citizens even despite a global pandemic and a very poor currency exchange rate, we have been able to increase our sales and make our products affordable for the struggling economy through adjusting our prices and offering payment plans.”
Before becoming Co-CEO of HempMeds®’ operations, Heinz served as Vice President of HempMeds® Brasil. She joined the Company in 2014 and helped pass legislation to get the Brazilian government to subsidize CBD for several indications. She was also able to establish two HempMeds® Brasil offices and create a network of Brazilian doctors and medical professionals.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, recently announced that it has entered into an exclusive distribution agreement with Rappi SAS, the leading Latin American last-mile multi-vertical platform that is backed with a USD 1 billion investment from Softbank Group Corp., and Softbank Vision Fund. The expansive agreement comprises a 6-month exclusive distribution partnership between Rappi and Khiron to introduce and distribute the Company's CPG product portfolio across Latin America through the Rappi platform, starting with KuidaTM, the Company's branded CBD skincare product line, with the potential to build on the partnership over time.
Beyond a standard vendor agreement, this expanded partnership introduces the Company's CBD-based Wellbeing products to millions of Rappi users across Latin America through its sophisticated technology and advanced customer-centric marketing strategies. With the Kuida store already launched on Rappi in May 2020 for the Colombian market, distribution will be expanded to Uruguay and Costa Rica, where Kuida has been recently approved. The Company also intends to introduce its product line through Rappi's fast growing consumer base to countries such as Brazil, Mexico, Ecuador and Chile, subject to regulatory approvals.
Colombia's Rappi is the market leading multi-vertical application in Latin America with a presence in Brazil, Colombia, Mexico, Argentina, Chile, Ecuador, Costa Rica, Uruguay and Peru.
Through its platform, customers buy products and services and receive home delivery across multiple categories, including, medical, health, grocery, restaurants, pharmacies, beverage and professional services among others. In addition, the application has a virtual wallet, RappiPayTM, where users can make P2P transfers and payments. Rappi has an average of more than 10 million active users monthly, according to research firm Apptopia, providing deliveries for almost 100,000 businesses in LatAm, including over 13 million deliveries in Colombia alone.
"Rappi is the delivery brand that everyone in Latin America knows and uses daily. The partnership with Rappi reduces our product launch and logistics costs and transforms our availability and exposure to millions of customers across the region. Rappi is the last-mile delivery brand that will help us bring Khiron product to more customers than ever before. We are proud to establish this first-of-its-kind partnership between these two companies, which are both industry leaders in LatAm, and were both founded by Colombians," comments Alvaro Torres, Khiron CEO and director.
"As the market for consumer cannabis products and services globalizes it is a natural fit for us to partner with Khiron to meet our app users´ needs. Like us, they are a recognized leader in the region, and an innovator in bringing quality products to market, "comments Simon Borrero, Rappi SAS CEO.
As the CBD/hemp space continues to gain global momentum, new distribution platforms and models as well as a heavy focus on product quality, consistency and efficacy will become more and more paramount for companies looking to be a global player and make no mistake, this is a global play. With companies like Amazon now also entering into the space, the level of competition has risen dramatically and investors should now be looking at the distribution and supply chain of any CBD/hemp company first and foremost as this looks to be an impactful factor moving forward.
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news article featuring CSUI is a paid for news release on Investorideas.com – third party (two thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800-665-0411
Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories
Buy a cannabis guest post on Investorideas.com
Subscribe to:
Posts (Atom)